Ursoliv: Ursodeoxycholic Acid (Ursoliv) must not be used in the presence of: Allergy to bile acids; Patients with gallstone complications such as biliary-gastrointestinal fistula, biliary obstruction, cholangitis, cholecystitis, pancreatitis or frequent biliary colic.
Ursodeoxycholic Acid (Ursoliv) is ineffective for the dissolution of calcified and pigment gallstones and is of no value in patients without a patent and functioning gallbladder.
Ursoliv 500: Ursodeoxycholic Acid (Ursoliv) film-coated tablets should not be used in patients with: Acute inflammation of the gall bladder or biliary tract; occlusion of the biliary tract (occlusion of the common bile duct or cystic duct); frequent episodes of biliary colic; radio-opaque calcified gallstones; impaired contractility of the gall bladder; hypersensitivity to bile acids or any excipient of the formulation.
When used in hepatobiliary disorders associated with cystic fibrosis in children aged 6 to 18 years: Unsuccessful portoenterostomy or without recovery of good bile flow in children with biliary atresia.
Other Services
Country
Account